Transcend Capital Advisors LLC Has $1.25 Million Stake in CVS Health Co. (NYSE:CVS)

Transcend Capital Advisors LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 6.9% in the fourth quarter, Holdings Channel reports. The fund owned 15,769 shares of the pharmacy operator’s stock after selling 1,164 shares during the period. Transcend Capital Advisors LLC’s holdings in CVS Health were worth $1,245,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. Atticus Wealth Management LLC grew its stake in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 219 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 243 shares during the last quarter. ZRC Wealth Management LLC grew its stake in CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the last quarter. Coston McIsaac & Partners grew its stake in shares of CVS Health by 42.6% during the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $50,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CVS. SVB Leerink initiated coverage on shares of CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price on the stock. Wells Fargo & Company dropped their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a report on Monday, April 8th. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Royal Bank of Canada dropped their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Trading Down 0.2 %

CVS traded down $0.15 during trading on Friday, reaching $67.18. 6,396,438 shares of the company’s stock were exchanged, compared to its average volume of 8,376,818. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $84.68 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The firm has a fifty day moving average price of $74.42 and a two-hundred day moving average price of $73.66.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same period in the previous year, the firm posted $1.99 EPS. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, equities research analysts forecast that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.96%. CVS Health’s payout ratio is presently 41.18%.

Insider Activity at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.24% of the stock is owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.